These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 684782)

  • 21. [Combination chemotherapy in advanced carcinoma of the breast].
    Carmo-Pereira J; Galvão-Teles A; Oliveira Costa F; Bak Gordon R; Henriques E; Dória JM; Freire Cruz M; Silveira Botelho L
    Arq Patol; 1974; 46(2-3):309-23. PubMed ID: 4458643
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy in breast cancer.
    Hanham IW
    Proc R Soc Med; 1974 Apr; 67(4):292-4. PubMed ID: 4453579
    [No Abstract]   [Full Text] [Related]  

  • 23. [Five-drug therapy in addition to hormonal treatment in advance breast cancer metastatic to the lung (author's transl)].
    Matthiessen W; Pochhammer KF
    Prax Pneumol; 1976 Aug; 30(8):479-8. PubMed ID: 959156
    [No Abstract]   [Full Text] [Related]  

  • 24. [Association of VCR-5FU-CYCLO-PDN in the treatment of disseminated carcinoma of the breast (author's transl)].
    Estapé J; Millá A; Prats M; Herranz M; Visa J
    Med Clin (Barc); 1979 Aug; 73(4):136-9. PubMed ID: 481010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hepatic metastases from breast cancer.
    Bugarski M; Vuletić L; Boberić J; Milosavljević A; Dilparić S; Tomin R; Naumović P
    Clin Oncol; 1978 Jun; 4(2):167-71. PubMed ID: 668248
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination chemotherapy for advanced mammary carcinoma: a twelve-year experience.
    Greenspan EM
    Mt Sinai J Med; 1972; 39(5):435-46. PubMed ID: 4628078
    [No Abstract]   [Full Text] [Related]  

  • 29. Doxorubicin in the treatment of advanced breast cancer; comparative studies of three combination chemotherapy regimes.
    Brown I; Ward HW
    Clin Oncol; 1976 Jun; 2(2):105-11. PubMed ID: 954258
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cytostatic therapy of inoperable carcinomas].
    Baumgartner G
    Wien Med Wochenschr; 1976 Jan; 126(5):59-61. PubMed ID: 986106
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone].
    Raevskiĭ IG
    Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408
    [No Abstract]   [Full Text] [Related]  

  • 32. Experimental chemotherapy in carcinoma of the cervix.
    Papadimitriou G; Razis D; Panopoulos C; Lappas C; Gnafakis N
    Int Surg; 1974 Sep; 59(9):472-5. PubMed ID: 4137657
    [No Abstract]   [Full Text] [Related]  

  • 33. [Induction chemotherapy in high risk breast cancer. Results of a prospective therapeutic study (author's transl)].
    Chauvergne J; Durand M; Hoerni B; Cohen P; Lagarde C
    Bull Cancer; 1979; 66(1):9-16. PubMed ID: 420953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [1st report on programmed chemotherapy of ovarian carcinoma].
    Frank S; Richter K; Ehrhart H; Penning W; Meister P; Schmidt D; Götz A
    Fortschr Med; 1975 Oct; 93(28):1309-12. PubMed ID: 1228086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidisciplinary curative treatment for disseminated carcinoma of the breast.
    Mannes P; Derriks R; Moens R; Laurent C; Dalcq JM
    Cancer Treat Rep; 1976 Jan; 60(1):85-9. PubMed ID: 1000521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The period of time between operation and irradiation of a mamma carcinoma and its cytostatic treatment (author's transl)].
    Dietz R; Tkocz HJ
    Strahlentherapie; 1979 Mar; 155(3):160-2. PubMed ID: 432888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytostatic therapy of metastasizing breast cancer].
    Schmidt G; Pittner W
    Z Allgemeinmed; 1973 Dec; 49(34):1690-2. PubMed ID: 4207852
    [No Abstract]   [Full Text] [Related]  

  • 38. Five-drug combination chemotherapy for disseminated adenocarcinoma.
    Lokich JJ; Skarin AT
    Cancer Chemother Rep; 1972 Dec; 56(6):761-7. PubMed ID: 4660632
    [No Abstract]   [Full Text] [Related]  

  • 39. Breast cancer 1984: state of the art.
    Sledge GW
    Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
    [No Abstract]   [Full Text] [Related]  

  • 40. Adjuvant treatment of cancer. II. Breast carcinoma.
    Viola MV; Nystrom JS
    Conn Med; 1977 Jun; 41(6):333-5. PubMed ID: 872584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.